• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植受者移植后1年调节性T细胞水平高可预测长期移植物存活。

High regulatory T-cell levels at 1 year posttransplantation predict long-term graft survival among kidney transplant recipients.

作者信息

San Segundo D, Fernández-Fresnedo G, Rodrigo E, Ruiz J C, González M, Gómez-Alamillo C, Arias M, López-Hoyos M

机构信息

Immunology Service, Hospital Universitario Marqués de Valdecilla-IFIMAV, Santander, Spain.

出版信息

Transplant Proc. 2012 Nov;44(9):2538-41. doi: 10.1016/j.transproceed.2012.09.083.

DOI:10.1016/j.transproceed.2012.09.083
PMID:23146447
Abstract

INTRODUCTION

Regulatory T cells (Tregs) have gained an important role in mechanisms of tolerance and protection against the transplant rejection. However, only limited retrospective data have shown a relationship between peripheral blood Tregs and better long-term graft survival. The purpose of the present study was to investigate prospectively circulating Treg levels and their association with long-term graft survival.

METHODS

Ninety kidney transplant recipients underwent measurement of Treg levels in peripheral blood before as well as at 6 months and 1 year posttransplantation. Receiver operating characteristic curves were applied to test the sensitivity and specificity of Treg levels to predict prognosis.

RESULTS

Treg levels before transplantation correlated with those at 6 months and 12 months posttransplantation (P < .001 and P = .002, respectively). Patients who maintained high Treg levels (above 70th percentile) at both 6 and 12 months displayed better long-term graft survival at 4 and 5 years follow-up (P = .04 and P = .043 respectively). There was no effect on patient survival.

CONCLUSION

Detection of high levels of peripheral blood Tregs was associated with better graft survival possibly using as a potential marker of prognosis.

摘要

引言

调节性T细胞(Tregs)在耐受机制以及预防移植排斥反应中发挥着重要作用。然而,仅有有限的回顾性数据表明外周血Tregs与更好的长期移植物存活之间存在关联。本研究的目的是前瞻性地调查循环Treg水平及其与长期移植物存活的关系。

方法

90名肾移植受者在移植前以及移植后6个月和1年测量外周血中的Treg水平。应用受试者工作特征曲线来测试Treg水平预测预后的敏感性和特异性。

结果

移植前的Treg水平与移植后6个月和12个月的水平相关(分别为P <.001和P =.002)。在6个月和12个月时均维持高Treg水平(高于第70百分位数)的患者在4年和5年随访时显示出更好的长期移植物存活(分别为P =.04和P =.043)。对患者存活没有影响。

结论

检测到外周血中高水平的Tregs可能与更好的移植物存活相关,可作为一种潜在的预后标志物。

相似文献

1
High regulatory T-cell levels at 1 year posttransplantation predict long-term graft survival among kidney transplant recipients.肾移植受者移植后1年调节性T细胞水平高可预测长期移植物存活。
Transplant Proc. 2012 Nov;44(9):2538-41. doi: 10.1016/j.transproceed.2012.09.083.
2
Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell count rather than its ratio in peripheral blood is related to long-term survival of renal allografts.外周血中CD4(+)CD25(+)FOXP3(+)调节性T细胞的绝对计数而非其比例与肾移植的长期存活相关。
Transplant Proc. 2012 Jan;44(1):284-6. doi: 10.1016/j.transproceed.2011.12.014.
3
Low circulating regulatory T-cell levels after acute rejection in liver transplantation.肝移植急性排斥反应后循环调节性T细胞水平降低。
Liver Transpl. 2006 Feb;12(2):277-84. doi: 10.1002/lt.20612.
4
Pretransplant Recipient Circulating CD4+CD127lo/- Tumor Necrosis Factor Receptor 2+ Regulatory T Cells: A Surrogate of Regulatory T Cell-Suppressive Function and Predictor of Delayed and Slow Graft Function After Kidney Transplantation.移植前受者循环CD4+CD127lo/-肿瘤坏死因子受体2+调节性T细胞:调节性T细胞抑制功能的替代指标及肾移植后移植肾功能延迟和缓慢的预测指标
Transplantation. 2016 Feb;100(2):314-24. doi: 10.1097/TP.0000000000000942.
5
An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.一项评估CD25高表达CD4 + T细胞在临床稳定的肾移植受者中调节对供体同种异体抗原反应潜力的研究。
Transpl Int. 2008 Jan;21(1):65-73. doi: 10.1111/j.1432-2277.2007.00560.x. Epub 2007 Sep 20.
6
Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.移植后可溶性CD30作为急性肾移植排斥反应的预测指标。
Exp Clin Transplant. 2009 Dec;7(4):237-40.
7
Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.肾移植中的短期抗CD25单克隆抗体治疗与新生CD4(+)CD25(高表达)调节性T细胞
Transpl Immunol. 2008 Apr;19(1):69-73. doi: 10.1016/j.trim.2008.01.005. Epub 2008 Feb 22.
8
FOXP3+ regulatory T-cells in renal allografts: correlation with long-term graft function and acute rejection.肾移植中FOXP3 + 调节性T细胞:与长期移植肾功能及急性排斥反应的相关性
Clin Nephrol. 2011 Feb;75(2):91-100.
9
Fetuin-A pretransplant serum levels, kidney allograft function and rejection episodes: a 3-year posttransplantation follow-up.移植前血清胎球蛋白 A 水平、肾移植功能和排斥反应发作:移植后 3 年随访。
Kidney Blood Press Res. 2011;34(5):328-33. doi: 10.1159/000327848. Epub 2011 May 26.
10
Correlation of immunological markers with graft vasculopathy development in heart transplantation.心脏移植中免疫标志物与移植血管病变发展的相关性
Transplant Proc. 2012 Nov;44(9):2653-6. doi: 10.1016/j.transproceed.2012.09.048.

引用本文的文献

1
Evaluating Activated Regulatory T Cells as a Biomarker of Chronic Allograft Inflammation in Pediatric Kidney Transplant Recipients.评估活化调节性T细胞作为小儿肾移植受者慢性移植肾炎症生物标志物的作用。
Pediatr Transplant. 2025 Mar;29(2):e70041. doi: 10.1111/petr.70041.
2
Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer.对CD3ε进行基因编辑,以重定向调节性T细胞用于过继性T细胞转移。
Mol Ther. 2025 Mar 5;33(3):997-1013. doi: 10.1016/j.ymthe.2025.01.045. Epub 2025 Feb 3.
3
Assessing Biomarkers of Porcine Kidneys under Normothermic Machine Perfusion-Can We Gain Insight into a Marginal Organ?
评估常温机械灌注下猪肾脏的生物标志物——我们能深入了解边缘器官吗?
Int J Mol Sci. 2024 Sep 24;25(19):10280. doi: 10.3390/ijms251910280.
4
Immune Profiling of Peripheral Blood Mononuclear Cells at Pancreas Acute Rejection Episodes in Kidney-Pancreas Transplant Recipients.肾胰联合移植受者胰腺急性排斥反应时外周血单个核细胞的免疫分析。
Transpl Int. 2022 Nov 18;35:10639. doi: 10.3389/ti.2022.10639. eCollection 2022.
5
Therapeutic Opportunities for Immunoreceptor-Engineered T Cell Therapy for Modulation of Alloimmunity.免疫受体工程化 T 细胞治疗在调节同种异体免疫中的治疗机会。
J Immunol. 2022 Nov 15;209(10):1811-1816. doi: 10.4049/jimmunol.2200542.
6
Uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related CCR5, CD86, CD8A, ITGAM, and PTPRC in kidney transplantation patients with allograft rejection.揭示诊断性免疫/缺氧/铁死亡/上皮间质转化相关的 CCR5、CD86、CD8A、ITGAM 和 PTPRC 在同种异体移植排斥的肾移植患者中的作用。
Ren Fail. 2022 Dec;44(1):1850-1865. doi: 10.1080/0886022X.2022.2141648.
7
Effect of panel reactive antibodies on T cell immunity reinstatement following renal transplantation.群体反应性抗体对肾移植后T细胞免疫恢复的影响。
World J Transplant. 2022 Oct 18;12(10):313-324. doi: 10.5500/wjt.v12.i10.313.
8
Effects of Desflurane and Sevoflurane anesthesia on regulatory T cells in patients undergoing living donor kidney transplantation: a randomized intervention trial.地氟烷和七氟烷麻醉对活体供肾移植患者调节性 T 细胞的影响:一项随机干预试验。
BMC Anesthesiol. 2020 Aug 27;20(1):215. doi: 10.1186/s12871-020-01130-7.
9
Decreased Foxp3 and function of Tregs caused immune imbalance and liver injury in patients with autoimmune liver diseases post-liver transplantation.肝移植后自身免疫性肝病患者中,Foxp3减少及调节性T细胞功能降低导致免疫失衡和肝损伤。
Ann Transl Med. 2020 Apr;8(8):534. doi: 10.21037/atm.2020.03.203.
10
Regulatory T-cell Number in Peripheral Blood at 1 Year Posttransplant as Predictor of Long-term Kidney Graft Survival.移植后1年外周血调节性T细胞数量作为长期肾移植存活的预测指标
Transplant Direct. 2019 Feb 8;5(3):e426. doi: 10.1097/TXD.0000000000000871. eCollection 2019 Mar.